Work with us to conduct your screening

We provide fully assisted Mass Spectrometry services at highly competitive rates. Our Mass Spectrometry facilities are world-leading and state of the art, and we are ready to assist you by providing a comprehensive screening service that will help you acheive your research goals.


At GRIDD we collaborate with industry, academia and government from around Australia and internationally, lending our collective expertise to a range of drug discovery and research projects. We are always happy to speak with potential collaborators who share the sentiments behind our GRIDD mission and values.

Contact Us

Don't hesitate to contact us for more information on our Mass Spectrometry screening services - please get in touch with Mass Spectrometry Facility Manager Dr Wendy Loa or GRIDD Strategic Development Manager Dr Raya Monteiro with your inquiry.

Want to know more?

Click here to enquire about using GRIDD's Mass Spectrometry Screening platform

Our Mass spectrometry facility

The GRIDD MS facility is equipped with state-of-the-art instruments. These high-resolution electrospray ionisation mass spectrometry instruments support a range of research projects focused on the study of proteins and complexes of protein with fragments, compounds and natural product extracts, known as bioaffinity mass spectrometry.

Our researchers have extensive expertise in applying high resolution mass spectrometry to identify new binding ligands to target proteins for drug discovery.

Bruker SolariX XR 12 Telsa ICR-FTMS

  • ESI and captive ESI nano spray source.
  • Chip-based ESI infusion is also possible with the available TriVersa NanoMate (Advion).
  • High mass resolution >10 million (isotopic resolution)
  • High mass range acquisition of up to 150 kDa
  • MS/MS analysis with fragmentation techniques that include collision induced dissociation, electron capture dissociation and electron transfer dissociation.

Main applications:

  • Advanced protein analysis including native protein analysis, quantification of protein/ ligand binding affinity, high throughput bioaffinity screening MS/MS analysis.
  • Small molecule analysis.
  • Complex mixtures, such as natural product extracts.

This equipment was purchased with assistance from an ARC LIEF grant.


  • ESI and captive ESI nano spray source with nanoBooster.
  • High-Mass option facilities, easier characterisation of high-molecular weight species and native state protein complexes.
  • Full sensitivity resolution of >80,000.
  • MS/MS analysis with fragmentation techniques that include collision induced dissociation and electron transfer dissociation.
  • Thermo Fisher Ultimate 3000 RS UHPLC is available for coupling.

Main applications:

  • Small molecule analysis for HRMS measurement.
  • Advanced protein analysis which includes native protein analysis, high throughput bioaffinity screening.

This equipment was purchased with assistance from the Griffith University research equipment infrastructure scheme.

Low-resolution instruments

These include:

  • Thermo Fisher Ultimate 3000 RS UHPLC-MSQ Plus Single Quadrupole Mass Spectrometer
  • Waters Alliance HPLC - Micromass Quattro micro API Triple Quadrupole Mass Spectrometer

High-resolution accurate mass measurement service

GRIDD provides high-resolution mass measurement to determine the molecular formula of chemical entities as a service for Griffith researchers and external organisations.

The sample submission form and guidelines are provided below.

Contact facility manager Dr Wendy Loa for details and quotes to use this service.

Success Stories

Sally Ann Mass Spec

GRIDD's Mass Spectrometry screening helped me discover a “hidden gem” in a fragment-based drug discovery research campaign. This finding provides credence for the relatively untapped opportunity to apply native state mass spectrometry as a complementary fragment screening method to accelerate drug discovery.

Professor Sally-Ann Poulsen
Principal Research Leader
Reference: and
Ron Quinn Mass Spec

A COVID-19 protein arrived the laboratory in the morning of 30 April, the screen development completed that afternoon and we are now ready to screen for antiviral compounds. This rapid response to COVID-19 was possible because of previous work on the malaria parasite [1] and the microorganism causing tuberculosis  [2] where we investigated more that 100 proteins from the respective proteomes.

Professor Ron Quinn
Principal Research Leader
Reference 1:
Reference 2:
Miaomiao Mass Spec

Native mass spectrometry is applied in our group in a combined approach of phenotypic screening and target screening, which we refer to as a PhenoTarget approach. We have showed the powerful potential of the PhenoTarget approach in identifying new lead compounds, from a natural product fraction library, as well as the target protein of the lead compounds.

Dr Miaomiao Liu
Research Fellow

Want to know more?

Get in touch with GRIDD